IL115391A0 - Use of muramyl peptide compounds - Google Patents

Use of muramyl peptide compounds

Info

Publication number
IL115391A0
IL115391A0 IL11539195A IL11539195A IL115391A0 IL 115391 A0 IL115391 A0 IL 115391A0 IL 11539195 A IL11539195 A IL 11539195A IL 11539195 A IL11539195 A IL 11539195A IL 115391 A0 IL115391 A0 IL 115391A0
Authority
IL
Israel
Prior art keywords
peptide compounds
muramyl peptide
muramyl
compounds
peptide
Prior art date
Application number
IL11539195A
Original Assignee
Peptech Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Uk Ltd filed Critical Peptech Uk Ltd
Publication of IL115391A0 publication Critical patent/IL115391A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL11539195A 1994-09-21 1995-09-21 Use of muramyl peptide compounds IL115391A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9419011A GB9419011D0 (en) 1994-09-21 1994-09-21 Use of muramyl peptide compounds

Publications (1)

Publication Number Publication Date
IL115391A0 true IL115391A0 (en) 1995-12-31

Family

ID=10761674

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11539195A IL115391A0 (en) 1994-09-21 1995-09-21 Use of muramyl peptide compounds

Country Status (13)

Country Link
EP (1) EP0782454A1 (en)
JP (1) JPH10506387A (en)
KR (1) KR970706015A (en)
AU (1) AU3527495A (en)
BG (1) BG101325A (en)
CA (1) CA2200570A1 (en)
CZ (1) CZ86197A3 (en)
GB (1) GB9419011D0 (en)
HU (1) HUT77741A (en)
IL (1) IL115391A0 (en)
SK (1) SK36697A3 (en)
WO (1) WO1996009063A1 (en)
ZA (1) ZA957997B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6693396A (en) * 1995-08-08 1997-03-05 Allergan, Inc. Method of increasing tear production by topical administration of muramyl peptide
DE10106852A1 (en) * 2001-02-14 2002-09-05 T Luger Anti-inflammatory compounds
CN108785251B (en) * 2018-01-23 2020-11-24 盛元医药广州有限公司 Medicinal composition for eyes and preparation method and application thereof
AU2022239614A1 (en) 2021-03-19 2023-10-12 Icahn School Of Medicine At Mount Sinai Compounds for regulating trained immunity, and their methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0026746B1 (en) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
EP0056560A1 (en) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics
EP0102319B1 (en) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections
DE69002950T2 (en) * 1989-07-19 1994-01-20 Upjohn Co PEPTIDES WITH DIAMINOGLYCOLES AS TRANSITIONAL MIME.
DE69230041T2 (en) * 1991-11-19 2000-01-05 Peptech Uk Ltd MURAMYL COMPOUNDS FOR TREATING SEPTIC SHOCK
US5679348A (en) * 1992-02-03 1997-10-21 Cedars-Sinai Medical Center Immunotherapy for recurrent HSV infections
MX9301789A (en) * 1992-04-03 1993-10-01 Iaf Biochem Int NEW LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY.

Also Published As

Publication number Publication date
SK36697A3 (en) 1997-11-05
CA2200570A1 (en) 1996-03-28
KR970706015A (en) 1997-11-03
JPH10506387A (en) 1998-06-23
WO1996009063A1 (en) 1996-03-28
ZA957997B (en) 1997-03-24
HUT77741A (en) 1998-07-28
BG101325A (en) 1998-01-30
AU3527495A (en) 1996-04-09
CZ86197A3 (en) 1997-08-13
EP0782454A1 (en) 1997-07-09
GB9419011D0 (en) 1994-11-09

Similar Documents

Publication Publication Date Title
GB9421709D0 (en) Therapeutic compounds
GR3033744T3 (en) Therapeutic compounds
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL113248A0 (en) Use of alpha - 1c specific compounds
EP0752873A4 (en) Labelled peptide compounds
ZA955763B (en) Use of muramyl peptide compounds
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
ZA959517B (en) Leutherobin and analogs thereof
IL113992A0 (en) Use of copolymer-1
ZA96725B (en) Use of phenyclyclohexylcarboxamides
IL115391A0 (en) Use of muramyl peptide compounds
GB9506372D0 (en) New peptide compounds
GB9413751D0 (en) Immunodominant peptides
GB9618673D0 (en) The use of muramyl peptides
GB9411594D0 (en) Demagnetisation of materials
NZ295530A (en) Preparation of 1-halo-3-trialkylsilanyl-benzenes
GB9422764D0 (en) Use of compound
GB9424408D0 (en) New peptide compounds
IL118225A0 (en) Use of felodipine
GB9418295D0 (en) Preparation of indoloquinone compounds
GB9722026D0 (en) Use of compounds
GB9414971D0 (en) Preparation of thionucleosides
HU9403029D0 (en) Praess for preparation of n-methoxy-acetyl-anilines
GB9510042D0 (en) New peptide compounds
GB9504891D0 (en) New peptide compounds